HopeStage
Back to all studies
CompletedNCT04037085

Ketamine After Cesarean Birth: Breastmilk Transfer and Effects

About this titleRead the official source — NCT04037085
Medication studyAges 18–99United StatesDepression
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 99 years.

What did participation involve?

The study group receives ketamine as a study medication.

Listed locations
Pittsburgh and 1 more locationSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: October 9, 2019
Recruitment status
Completed
Enrollment listed in the registry
8
Sponsor
Grace Lim, MD, MS
Sponsor type
Individual investigator
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 99 Years
Official registry ID
NCT04037085
Official title
Show the full official title

Evaluation of PK/PD, Breastmilk Transfer, and Effectiveness of Ketamine After Cesarean Delivery - Part 1

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Pittsburgh

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Grace Lim, MD, MS.

Did this study involve medication?

Yes. The study involved medication, including ketamine.

Who was this study for?

Listed age limits: 18 years to 99 years.

Want to explore more studies?

Explore studies